CCC 2014: Recent Advances in the Management of Atrial Fibrillation
Until the new oral anticoagulant (NOAC) drugs became available, beginning in 2009, warfarin was the workhorse for managing stroke risk in patients with atrial fibrillation. In his Research Achievement Award presentation, Stuart Connolly, MD, of McMaster University in Hamilton, Ont., provided a
CCC and AHA 2014: Overcoming Challenges to Repair Heart Attack Damage
We know the best ways to prevent a heart attack. Healthy eating, being physically active and not smoking are key among them. And advances in cardiac care are helping people live longer and with a better quality of life if they do have a heart attack. But there is no way to repair the damage and
CCC 2014: Seeing Inside the Heart
At the 2014 Canadian Cardiovascular Congress and American Heart Association Scientific Sessions, Heart Institute researchers presented several studies that tested novel ways to visualize the heart’s structure and function. Developing methods to predict which plaques in the arteries may be at high
AHA 2014 Highlights
Research from around the world was presented at the 2014 American Heart Association (AHA) Scientific Sessions in November. The following highlights range from large drug trials to new information about the causes and of heart disease and the value of good heart health. Preventing Clots Following
CCC and AHA 2014 Conference Highlights
Read detailed coverage of CCC and AHA 2014 – highlights include text messaging and mobile apps for health promotion, updates on atrial fibrillation and the future of cardiac rehabilitation. CCC 2014: Presentations and Activities Schedule (pdf) AHA 2014: Presentations and Activities Schedule (pdf)
CCC 2014: Gaining Weight Over Time Can Start the Process of Heart Disease
The arteries in our body are lined with a layer of cells called the endothelium. The very first step in the development of cardiovascular disease—the primary cause of heart attack and stroke—takes place when the endothelium begins to function abnormally. In research presented at the Canadian
CCC 2014:Heart Institute Program Guide
The Canadian Cardiovascular Congress travels to the West Coast this year. With topics ranging from sedentary behaviour to stem cells, the University of Ottawa Heart Institute has more than 90 items on the program at CCC 2014. Our program guide will help you find them all. Presentations and
Global Ranking Confirms the High Impact of Heart Institute Research
The latest global ranking of research organizations from Scimago Institutions Rankings (SIR) recognizes the continued excellence and vitality of research at the University of Ottawa Heart Institute, placing it 159th out of 4,851 institutions worldwide, across all fields of study. In Canada, the
Ottawa to Become National Hub for Medical Device Commercialization
Much of modern health care is made possible by medical devices—the countless tools, equipment and instruments used in health care delivery and patient care. Pocket glucose monitors that check blood sugar levels on the go. Specialized retractors that support new surgical techniques. Cardiac stents
Aortic Disease: The Elephant in the Room
Aortic disease is often referred to as a silent condition because there are usually no symptoms to alert either the patient or doctor. The consequences, however, can be catastrophic, as in the case of an aortic dissection—a tear in the wall of this major artery. Rapid diagnosis and treatment are